Vitamin Shoppe Inc (NYSE:VSI) has been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $5.00.
Several brokerages have weighed in on VSI. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Barclays lowered their price target on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Morgan Stanley reiterated an “equal weight” rating and set a $7.50 price target (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Finally, Zacks Investment Research cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th.
In other Vitamin Shoppe news, major shareholder Vintage Capital Management Llc acquired 133,804 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were acquired at an average cost of $4.28 per share, for a total transaction of $572,681.12. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.07% of the company’s stock.
Shares of Vitamin Shoppe (NYSE:VSI) traded down $0.05 during midday trading on Monday, hitting $5.25. The company had a trading volume of 1,020,000 shares, compared to its average volume of 613,118. The company has a market cap of $125.88, a P/E ratio of -0.50 and a beta of 0.68. Vitamin Shoppe has a 1-year low of $2.95 and a 1-year high of $23.85. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59.
Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.20). The business had revenue of $288.20 million for the quarter, compared to the consensus estimate of $297.61 million. Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The firm’s revenue was down 8.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.50 EPS. equities research analysts forecast that Vitamin Shoppe will post 0.34 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Vitamin Shoppe Inc (VSI) Receives Average Recommendation of “Hold” from Analysts” was posted by BBNS and is the property of of BBNS. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/vitamin-shoppe-inc-vsi-receives-average-recommendation-of-hold-from-analysts/1818697.html.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.